Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD: A Randomized Controlled Trial

NCT06570213 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT06570213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD: A Randomized Controlled Trial
Lead sponsor
Rush University Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2026
Completion date
December 31, 2029
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd